These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


135 related items for PubMed ID: 1415145

  • 1. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam.
    van Ameijden EJ, van den Hoek JA, van Haastrecht HJ, Coutinho RA.
    Am J Epidemiol; 1992 Jul 15; 136(2):236-43. PubMed ID: 1415145
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study.
    Nicolosi A, Leite ML, Musicco M, Molinari S, Lazzarin A.
    Am J Epidemiol; 1992 Feb 01; 135(3):225-33. PubMed ID: 1312300
    [Abstract] [Full Text] [Related]

  • 5. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.
    Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M, Amsterdam Cohort.
    Addiction; 2007 Sep 01; 102(9):1454-62. PubMed ID: 17697278
    [Abstract] [Full Text] [Related]

  • 6. Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs.
    van Ameijden EJ, van den Hoek AR, Coutinho RA.
    Am J Public Health; 1994 Feb 01; 84(2):275-81. PubMed ID: 8296953
    [Abstract] [Full Text] [Related]

  • 7. HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in Amsterdam.
    Hartgers C, van den Hoek A, Krijnen P, Coutinho RA.
    Am J Public Health; 1992 Apr 01; 82(4):547-51. PubMed ID: 1312311
    [Abstract] [Full Text] [Related]

  • 8. Migrant injecting users: characteristics of Italian drug users living in Amsterdam.
    Davoli M, Fennema H, Perucci CA, Montiroli PM, van den Hoek A.
    Subst Use Misuse; 1996 Jan 01; 31(1):127-39. PubMed ID: 8838398
    [Abstract] [Full Text] [Related]

  • 9. Risk contexts and risk behaviors in the Euregion Maas-Rhein: the Boule de Neige intervention for AIDS prevention among drug users.
    Franken IH, Kaplan CD.
    AIDS Educ Prev; 1997 Apr 01; 9(2):161-80. PubMed ID: 9167801
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HIV seroconversion and disinfection of injection equipment among intravenous drug users, Baltimore, Maryland.
    Vlahov D, Muñoz A, Celentano DD, Cohn S, Anthony JC, Chilcoat H, Nelson KE.
    Epidemiology; 1991 Nov 01; 2(6):444-6. PubMed ID: 1790197
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study.
    Lindenburg CE, Krol A, Smit C, Buster MC, Coutinho RA, Prins M.
    AIDS; 2006 Aug 22; 20(13):1771-5. PubMed ID: 16931942
    [Abstract] [Full Text] [Related]

  • 14. Differences in risk factors for human immunodeficiency virus type 1 seroconversion among male and female intravenous drug users.
    Solomon L, Astemborski J, Warren D, Muñoz A, Cohn S, Vlahov D, Nelson KE.
    Am J Epidemiol; 1993 Apr 15; 137(8):892-8. PubMed ID: 8484380
    [Abstract] [Full Text] [Related]

  • 15. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md.
    Nelson KE, Vlahov D, Solomon L, Cohn S, Muñoz A.
    Arch Intern Med; 1995 Jun 26; 155(12):1305-11. PubMed ID: 7778962
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS, Nasir A, Stanekzai MR, Fiekert K, Sipsma HL, Vlahov D, Strathdee SA.
    Harm Reduct J; 2015 Oct 16; 12():22. PubMed ID: 26472126
    [Abstract] [Full Text] [Related]

  • 17. Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study.
    Langendam MW, van Brussel GH, Coutinho RA, van Ameijden EJ.
    AIDS; 1999 Sep 10; 13(13):1711-6. PubMed ID: 10509573
    [Abstract] [Full Text] [Related]

  • 18. Behavioral characteristics of seroconverted intravenous drug users.
    Nemoto T.
    Int J Addict; 1992 Dec 10; 27(12):1413-21. PubMed ID: 1452392
    [Abstract] [Full Text] [Related]

  • 19. Operating needle exchange programmes in the hills of Thailand.
    Gray J.
    AIDS Care; 1995 Dec 10; 7(4):489-99. PubMed ID: 8547363
    [Abstract] [Full Text] [Related]

  • 20. Needle exchange use among a cohort of injecting drug users.
    Schoenbaum EE, Hartel DM, Gourevitch MN.
    AIDS; 1996 Dec 10; 10(14):1729-34. PubMed ID: 8970694
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.